Cardiovascular disorders are distinctly correlated with smoking and obesity. Smoking makes blood vessels more likely to develop plaque. Smoke from cigarettes contains chemicals that make blood thicken and clot in veins and arteries. When the arteries that provide blood to the heart are constricted by plaque or clogged by clots, coronary heart disease develops. Because of this, smokers are much more likely than non-smokers to acquire Interventional Cardiology Devices.
The CDC estimates that smoking-related deaths affect more than 480,000 people annually in the US alone. The sub-segment for drug-eluting stents is expected to experience significant increase. Drug-eluting stents are used to assist stop the development of scar tissue in the arterial lining by coating them with medication that is gradually released. By keeping the artery smooth and wide open, this promotes healthy blood flow. These stents perform better than self-expanding and balloon-expanding stents and are typically utilised for the lower extremities. Thus, the rising use of cutting-edge cardiovascular treatments and the development of drug-eluting stent technology.